BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3338022)

  • 1. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis.
    Rutgers JL; Scully RE
    Cancer; 1988 Feb; 61(3):546-54. PubMed ID: 3338022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
    Rutgers JL; Scully RE
    Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Müllerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter.
    Watkins JC; Young RH
    Int J Gynecol Pathol; 2022 Jan; 41(1):68-75. PubMed ID: 33577227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.
    Dubé V; Roy M; Plante M; Renaud MC; Têtu B
    Int J Gynecol Pathol; 2005 Apr; 24(2):138-46. PubMed ID: 15782070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive immunohistochemical analysis of the gastrointestinal and Müllerian phenotypes of 139 ovarian mucinous cystadenomas.
    Halimi SA; Maeda D; Ushiku-Shinozaki A; Goto A; Oda K; Osuga Y; Fujii T; Ushiku T; Fukayama M
    Hum Pathol; 2021 Mar; 109():21-30. PubMed ID: 33275953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zollinger-Ellison syndrome due to a borderline mucinous cystadenoma of the ovary.
    Garcia-Villanueva M; Badia Figuerola N; Ruiz del Arbol L; Hernandez Ortiz MJ
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):549-52. PubMed ID: 2304735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian epithelial tumors of borderline malignancy in Japan.
    Nakashima N; Nagasaka T; Oiwa N; Nara Y; Fukata S; Fukatsu T; Takeuchi J
    Gynecol Oncol; 1990 Jul; 38(1):90-8. PubMed ID: 2162318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A serous cystadenoma of the ovary of borderline malignancy with a fifteen-year history. A case report].
    Nagata O; Aramaki S; Iino H; Ishikawa S; Yoshida H; Azekami M; Yamaguchi Y; Iwasa T; Matsukuma K; Iwata Y
    Gan No Rinsho; 1990 Apr; 36(5):669-73. PubMed ID: 2325270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mullerianosis of the mesosalpinx: a case report.
    Lim S; Kim JY; Park K; Kim BR; Ahn G
    Int J Gynecol Pathol; 2003 Apr; 22(2):209-12. PubMed ID: 12649681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
    Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
    Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
    Eltabbakh GH; Mount SL
    J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystadenoma of spermatic cord resembling ovarian serous epithelial tumour of low malignant potential: immunohistochemical study suggesting Müllerian differentiation.
    McCluggage WG; Shah V; Nott C; Clements B; Wilson B; Hill CM
    Histopathology; 1996 Jan; 28(1):77-80. PubMed ID: 8838125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of endometriosis within serous and mucinous tumors of the ovary.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(2):140-2. PubMed ID: 22400074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.